X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2065) 2065
Publication (205) 205
Book Review (45) 45
Conference Proceeding (3) 3
Book Chapter (1) 1
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1537) 1537
oncology (1226) 1226
index medicus (1151) 1151
2nd-line treatment (938) 938
female (938) 938
middle aged (804) 804
chemotherapy (800) 800
male (748) 748
aged (726) 726
adult (637) 637
treatment outcome (544) 544
antineoplastic combined chemotherapy protocols - therapeutic use (535) 535
cancer (535) 535
2nd-line chemotherapy (387) 387
care and treatment (326) 326
2nd-line therapy (324) 324
pharmacology & pharmacy (324) 324
antineoplastic agents - therapeutic use (323) 323
lung neoplasms - drug therapy (322) 322
cisplatin (318) 318
open-label (292) 292
docetaxel (285) 285
phase-ii trial (283) 283
double-blind (277) 277
paclitaxel (269) 269
disease-free survival (264) 264
aged, 80 and over (254) 254
phase-iii trial (253) 253
gemcitabine (248) 248
antineoplastic combined chemotherapy protocols - adverse effects (245) 245
1st-line treatment (240) 240
therapy (239) 239
carcinoma, non-small-cell lung - drug therapy (238) 238
trial (229) 229
research (216) 216
clinical trials (212) 212
carcinoma (210) 210
drug therapy (209) 209
metastasis (200) 200
drug administration schedule (195) 195
survival (190) 190
phase-ii (189) 189
deoxycytidine - analogs & derivatives (185) 185
retrospective studies (184) 184
prognosis (183) 183
survival rate (183) 183
analysis (173) 173
survival analysis (173) 173
medicine & public health (172) 172
gastroenterology & hepatology (171) 171
neoplasm staging (168) 168
supportive care (152) 152
efficacy (151) 151
hematology, oncology and palliative medicine (150) 150
carboplatin (147) 147
combination (147) 147
neoplasm metastasis (147) 147
lung neoplasms - pathology (145) 145
deoxycytidine - administration & dosage (141) 141
lung cancer (140) 140
salvage therapy (140) 140
respiratory system (138) 138
irinotecan (135) 135
drug therapy, combination (134) 134
2nd-line (133) 133
ovarian neoplasms - drug therapy (133) 133
neoplasm recurrence, local - drug therapy (132) 132
randomized-trial (131) 131
multicenter (130) 130
disease progression (128) 128
bevacizumab (127) 127
antineoplastic agents (126) 126
non-small cell lung cancer (126) 126
oxaliplatin (126) 126
paclitaxel - administration & dosage (126) 126
antineoplastic combined chemotherapy protocols - administration & dosage (125) 125
erlotinib (125) 125
health aspects (125) 125
drug resistance, neoplasm (124) 124
cell lung-cancer (122) 122
lung cancer, non-small cell (122) 122
patients (122) 122
1st-line therapy (121) 121
cancer therapies (119) 119
antimitotic agents (117) 117
randomized phase-iii (116) 116
topotecan (116) 116
prospective studies (115) 115
antineoplastic agents - adverse effects (114) 114
cancer research (112) 112
adenocarcinoma - drug therapy (111) 111
mutation (110) 110
adenocarcinoma (109) 109
taxoids - administration & dosage (109) 109
randomized controlled trials as topic (107) 107
antineoplastic agents - administration & dosage (104) 104
helicobacter pylori (103) 103
cisplatin - administration & dosage (102) 102
stomach neoplasms - drug therapy (101) 101
combination chemotherapy (100) 100
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Helicobacter, ISSN 1083-4389, 10/2017, Volume 22, Issue 5, pp. e12423 - n/a
Journal Article
Journal Article
Journal Article